Algert Global’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-79,218
Closed -$1.4M 1285
2024
Q4
$1.4M Sell
79,218
-3,703
-4% -$70.2K 0.03% 713
2024
Q3
$1.9M Buy
82,921
+40,182
+94% +$908K 0.05% 567
2024
Q2
$981K Buy
42,739
+3,700
+9% +$114K 0.03% 693
2024
Q1
$1.55M Buy
39,039
+12,298
+46% +$486K 0.06% 496
2023
Q4
$1.06M Sell
26,741
-970
-4% -$40.6K 0.04% 604
2023
Q3
$1.23M Sell
27,711
-790
-3% -$34.5K 0.06% 520
2023
Q2
$1.24M Buy
28,501
+1,260
+5% +$55.4K 0.05% 577
2023
Q1
$1.19M Buy
27,241
+2,944
+12% +$130K 0.06% 577
2022
Q4
$906K Buy
24,297
+4,440
+22% +$172K 0.05% 607
2022
Q3
$790K Buy
19,857
+1,167
+6% +$43.2K 0.05% 638
2022
Q2
$715K Buy
18,690
+4,930
+36% +$178K 0.05% 616
2022
Q1
$546K Buy
+13,760
New +$539K 0.04% 775
2021
Q1
Sell
-5,490
Closed -$235K 497
2020
Q4
$235K Hold
5,490
0.07% 331
2020
Q3
$270K Hold
5,490
0.09% 273
2020
Q2
$320K Sell
5,490
-160
-3% -$8.45K 0.11% 261
2020
Q1
$257K Buy
5,650
+520
+10% +$31.2K 0.11% 270
2019
Q4
$338K Buy
+5,130
New +$314K 0.1% 248
2017
Q4
Sell
-11,620
Closed -$438K 342
2017
Q3
$438K Sell
11,620
-2,655
-19% -$83.4K 0.1% 236
2017
Q2
$384K Buy
+14,275
New +$349K 0.11% 229

Other funds holding NRC

Algert Global's NRC Position: Q1 2025 in Review

Algert Global sold out of NRC Health Common Stock (NRC) in Q1 2025, closing a stake of 79,218 shares — an estimated $1.4M sold.

Algert Global first reported a position in NRC in Q2 2017 and held it in 19 quarters. The position peaked at $1.9M in Q3 2024. 123 funds tracked by Wall St. Rank hold NRC as of Q1 2025.

  • Algert Global reported no remaining NRC Health Common Stock position as of Q1 2025 after selling out during the quarter.
  • Algert Global sold 79,218 NRC Health Common Stock shares in Q1 2025, an estimated $1.4M.
  • Algert Global first reported a position in NRC Health Common Stock in Q2 2017 and held it in 19 quarters.
  • Algert Global's NRC Health Common Stock position peaked at $1.9M in Q3 2024.
  • 123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2025.

Based on Algert Global's 13F filing for Q1 2025, filed 13 May 2025.